BBB: Permeable Conjugate of Exogenic GABA

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Neurotransmitters are crucial for managing nervous system disorders.
• Stroke and cerebral ischemia are linked to excessive glutamate release.
• Gamma-aminobutyric acid (GABA) is a key inhibitory neurotransmitter that counteracts glutamate.

Purpose of the Study:

• To investigate the potential of chemically synthesized GABA conjugated to a peptide for crossing the blood-brain barrier.
• To determine if this conjugated GABA can increase GABA levels in the brain and affect animal behavior.

Main Methods:

• Custom chemical synthesis of GABA conjugated to a cytoplasmic transduction peptide (YGRRARRRRRR).
• Administration of the conjugated GABA to rats and mice.
• Measurement of GABA levels in plasma.
• Observation of behavioral changes such as calmness and somnolence.

Main Results:

• The synthesized GABA-peptide conjugate successfully penetrated the blood-brain barrier.
• Elevated GABA levels were observed in the plasma of treated rodents.
• The rodents exhibited a noticeable state of calmness and somnolence.

Conclusions:

• Conjugating GABA to a specific peptide enables its passage through the blood-brain barrier.
• This approach offers a potential strategy for delivering GABA to treat neurological conditions associated with neurotransmitter imbalance.
• The findings suggest a novel therapeutic avenue for conditions like stroke/cerebral ischemia.